QA: Blueprint Medicines Corp in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001597264_2021_Blueprint_Medicines_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001597264, Blueprint Medicines Corp

  xvar xval
0 AssetsCurrent 927,759,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 34,129,000
3 remainder_Assets 756,505,000
4 LiabilitiesCurrent 130,802,000
5 LiabilitiesNoncurrent 117,503,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 425,000
8 SellingGeneralAndAdministrativeExpense 464,398,883
9 ResearchAndDevelopmentExpense 317,020,238
10 remainder_Expenses 1,058,000
11 remainder_Revenues 4,409,514,821
12 remainder_NetIncome 2,783,579
13 remainder_ComprehensiveNetIncome -2,674,300
  yvar yval
0 Assets 1,718,393,000
1 Liabilities 248,305,000
2 Expenses 782,902,121
3 Revenues 4,409,514,821
4 StockholdersEquity 1,470,088,000
5 NetIncome 3,629,396,279
6 ComprehensiveNetIncome 3,628,059,129
7 BaseVar 3,582,286,410
8 EconomicCapitalRatiobeforeLimitedLiability 6.95
9 EconomicCapitalRatio 6.98

Edgar->Model Mapping

Feature Distribution

Change over Time